• Profile
Close

Epilutein for early-stage age-related macular degeneration: A randomized and prospective study

Ophthalmic Research Oct 29, 2017

Forte R, et al. - The authors explored the proposition that oral supplementation of the epilutein/lutein combination could augment the macular pigment optical density (MPOD), in patients with age-related macular degeneration (AMD). A connection was found between the administration of lutein in combination with epilutein with an increased MPOD compared to the administration of lutein alone.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay